NeoPhore
Latest round
- Series B
Last raised
- Jan 2024
Total raised
- $43M
Investors
- 7
About NeoPhore
Based in Cheshire, UK, and founded in 2017, NeoPhore Ltd. operates as a biotechnology company that develops small-molecule therapies. The company was founded by Alberto Bardelli. In April 2024, NeoPhore Ltd.10 million post-money. NeoPhore offers novel small-molecule immuno-oncology therapeutics. The company develops small-molecule drugs to treat cancer.
Who invested in NeoPhore
7 investors across 3 rounds
See all investors in NeoPhore
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NeoPhore
Who invested in NeoPhore?
NeoPhore has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeoPhore raised?
NeoPhore has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NeoPhore last raise money?
NeoPhore's most recent round on record is a Series B, in Jan 2024.
What does NeoPhore do?
Based in Cheshire, UK, and founded in 2017, NeoPhore Ltd.
Where is NeoPhore headquartered?
NeoPhore is headquartered in Cheshire, UK.
Which VCs invest in companies like NeoPhore?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at NeoPhore's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NeoPhore? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.